Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Thioredoxin: friend or foe in human disease?

Burke-Gaffney A, Callister ME, Nakamura H.

Trends Pharmacol Sci. 2005 Aug;26(8):398-404. Review. Erratum in: Trends Pharmacol Sci. 2006 Jan;27(1):9.

PMID:
15990177
2.

The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy.

Biaglow JE, Miller RA.

Cancer Biol Ther. 2005 Jan;4(1):6-13. Epub 2004 Jan 8. Review.

PMID:
15684606
3.

Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.

Tonissen KF, Di Trapani G.

Mol Nutr Food Res. 2009 Jan;53(1):87-103. doi: 10.1002/mnfr.200700492. Review.

PMID:
18979503
4.

Redox control of cellular function by thioredoxin; a new therapeutic direction in host defence.

Nishinaka Y, Nakamura H, Masutani H, Yodoi J.

Arch Immunol Ther Exp (Warsz). 2001;49(4):285-92. Review.

PMID:
11726031
5.

Thioredoxin signaling as a target for cancer therapy.

Powis G, Kirkpatrick DL.

Curr Opin Pharmacol. 2007 Aug;7(4):392-7. Epub 2007 Jul 3. Review.

PMID:
17611157
6.

Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer.

Nakamura H, Masutani H, Yodoi J.

Semin Cancer Biol. 2006 Dec;16(6):444-51. Epub 2006 Sep 26. Review.

PMID:
17095246
7.

Oxygen sensing and redox signaling: the role of thioredoxin in embryonic development and cardiac diseases.

Kobayashi-Miura M, Shioji K, Hoshino Y, Masutani H, Nakamura H, Yodoi J.

Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2040-50. Epub 2007 Feb 9. Review.

8.

Thioredoxin-1 is a novel and attractive therapeutic approach for various diseases including cardiovascular disorders.

Billiet L, Rouis M.

Cardiovasc Hematol Disord Drug Targets. 2008 Dec;8(4):293-6. Review.

PMID:
19075641
9.

The thioredoxin-thioredoxin reductase system: over-expression in human cancer.

Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM.

Anticancer Res. 2003 May-Jun;23(3B):2425-33.

PMID:
12894524
10.

High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.

Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D.

Clin Chim Acta. 2006 May;367(1-2):156-61. Epub 2006 Feb 3.

PMID:
16458876
11.

Thioredoxin in the cardiovascular system.

World CJ, Yamawaki H, Berk BC.

J Mol Med (Berl). 2006 Dec;84(12):997-1003. Epub 2006 Oct 5. Review.

PMID:
17021908
12.

The thioredoxin system as a therapeutic target in human health and disease.

Mahmood DF, Abderrazak A, El Hadri K, Simmet T, Rouis M.

Antioxid Redox Signal. 2013 Oct 10;19(11):1266-303. doi: 10.1089/ars.2012.4757. Epub 2013 Feb 26. Review.

PMID:
23244617
13.

The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process.

Yoshida T, Nakamura H, Masutani H, Yodoi J.

Ann N Y Acad Sci. 2005 Dec;1055:1-12. Review.

PMID:
16387713
15.

Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system.

Berndt C, Lillig CH, Holmgren A.

Am J Physiol Heart Circ Physiol. 2007 Mar;292(3):H1227-36. Epub 2006 Dec 15. Review.

16.

Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl.

Andoh T, Chock PB, Murphy DL, Chiueh CC.

Mol Pharmacol. 2005 Nov;68(5):1408-14. Epub 2005 Aug 12.

17.

The thioredoxin system in cancer.

Arnér ES, Holmgren A.

Semin Cancer Biol. 2006 Dec;16(6):420-6. Epub 2006 Oct 28. Review.

PMID:
17092741
18.

Thioredoxin and thioredoxin binding protein 2 in the liver.

Okuyama H, Son A, Ahsan MK, Masutani H, Nakamura H, Yodoi J.

IUBMB Life. 2008 Oct;60(10):656-60. doi: 10.1002/iub.102. Review.

19.

High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation.

Luan R, Liu S, Yin T, Lau WB, Wang Q, Guo W, Wang H, Tao L.

Cardiovasc Res. 2009 Jul 15;83(2):294-302. doi: 10.1093/cvr/cvp085. Epub 2009 Mar 10.

PMID:
19276128
20.

Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues.

Hashemy SI, Holmgren A.

J Biol Chem. 2008 Aug 8;283(32):21890-8. doi: 10.1074/jbc.M801047200. Epub 2008 Jun 10.

Supplemental Content

Support Center